A major cyberattack has targeted pharmaceutical giant AstraZeneca. Hackers claim they stole internal company data and later ...

By Pushkala Aripaka and Nithyashree R B March 27 (Reuters) - AstraZeneca's experimental drug tozorakimab reduced flare-ups of ...

The European Union is calling out vaccine makers AstraZeneca and Pfizer over delivery delays that could slow its recovery from the pandemic. Officials are even threatening to restrict exports and take ...

The highlight of AstraZeneca's latest results is the maintained full-year outlook despite the recent US drug pricing agreement. AstraZeneca's financials remain robust, with double-digit revenue and ...

AstraZeneca is facing some headwinds related to its operations in China. Still, the company's financial results and pipeline look strong. The stock could deliver solid returns for those who invest at ...